{"transactions":[{"id":2751232,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":4740,"kind":"organization","name":"HARROW, INC.","position":1,"cik":"0001360214","reported_name":"HARROW HEALTH, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T23:55:03.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1518000,"price":7,"value":10626000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 12, 2021, Harrow Health, Inc., a Delaware corporation (the \"Company\"), closed the previously announced underwritten public offering of 1,518,000 shares of common stock of Eton Pharmaceuticals, Inc. at a public offering price of $7.00 per share, including 198,000 shared issued pursuant to the full exercise by the underwriter, National Securities Corporation, of its over-allotment option. The gross proceeds to the Company from the offering were approximately $10.6 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company."}],"balance_after":1982000,"source":{"system":"sec-edgar","filing":"0001493152-21-008584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315221008584/ownership.xml","form_type":"4"}}]}